Skip to main content
OpenTrials

Clinical trial condition

Essential Hypertension

Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.

369 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Essential Hypertension trial results

Completed

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

NCT01151410

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Dalton, Georgia, United States
View all 36 locations
View Trial Details
Completed

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

NCT01193101

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Shijiazhuang, Hebei, China
  • Novartis Investigative Site Tianjin, Tianjin Municipality, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 34 locations
View Trial Details
Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

NCT01615198

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Changsha, Hunan, China
  • Novartis Investigative Site Suzhou, Jiangsu, China
  • Novartis Investigative Site Shenyang, Liaoning, China
View all 79 locations
View Trial Details
Completed

Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine

NCT01663233

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Shijiazhuang, Hebei, China
  • Novartis Investigative Site Chongqing, China
  • Novartis Investigative Site Shanghai, China
  • Novartis Investigative Site Tianjin, China
View all 28 locations
View Trial Details
Completed

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

NCT01256411

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Shijiazhuang, Hebei, China
  • Novartis Investigative Site Hangzhou, Zhejiang, China
  • Novartis Investigative Site Beijing, China
View all 33 locations
View Trial Details
Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

NCT01599104

Conditions
Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
Locations
  • Novartis Investigative Site Kamogawa, Chiba, Japan
  • Novartis Investigative Site Chikushi-gun, Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Fukuoka, Japan
View all 61 locations
View Trial Details

Related conditions